Biography
Prof Susanne J. van Veluw is a vascular neuroscientist who has dedicated her career to understanding the pathological underpinnings and disease mechanisms in cerebral amyloid angiopathy (CAA), one of the most common forms of cerebral small vessel disease affecting the brains of older individuals. After obtaining her PhD at the University of Utrecht (the Netherlands) in 2015, Susanne moved to the United States to pursue her post-doctoral training with Prof Steven Greenberg at the Massachusetts General Hospital in Boston. After joining the faculty at the department of Neurology and Harvard Medical School, she established the translational CAA research laboratory. In 2025, she moved to the UK as one of the new Group Leaders in the BHF-UK DRI Centre for Vascular Dementia Research at the University of Edinburgh. Furthermore, Prof van Veluw co-leads the Leducq Foundation Transatlantic Network of Excellence on Brain Clearance and currently serves on the board of the International CAA Association as vice-chair.
Her translational research lab uses a range of complementary techniques and approaches, including in vivo MRI in patients, ex vivo MRI-guided histopathology in human brain tissue, and in vivo two-photon microscopy in mice to unravel the pathophysiology of microvascular injury in CAA with the goal to discover novel targets for much needed intervention strategies.
News
